Novo Nordisk A/s(NVO)
$131.89
Market is closed - opens 7 PM, 20 May 2024
Insights
- Novo Nordisk A/s is currently in a neutral trading position according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Novo Nordisk A/s stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Novo Nordisk A/s stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Novo Nordisk A/s stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 58.62 | Neutral |
Stochastic | 78.52, 88.2 | Neutral |
Ultimate Oscillator | 57.57 | Neutral |
Stochastic Relative Strength Index | 81.96, 91.73 | Sell |
Moving Average Convergence Divergence | 1.76, 1.03 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 130.06 | Buy |
20 | 128.24 | Buy |
50 | 128.16 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 130.69 | Buy |
20 | 129.03 | Buy |
50 | 126.48 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 129.87 | Neutral |
20 | 127.86 | Neutral |
50 | 128.54 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 132.92 | Buy |
20 | 131.08 | Buy |
50 | 131.07 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 133.71 | Buy |
20 | 132.4 | Buy |
50 | 130.04 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 134.84 |
Resistance L2 | 134.25 |
Resistance L1 | 133.65 |
Pivot Point | 133.06 |
Support L1 | 132.46 |
Support L2 | 131.87 |
Support L3 | 131.27 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.